I was one of about 370,000 folks that participated in this study – one of the approximately 360,000 that did not have Parkinsons. Following is a teaser from the full article at the 23andMe blog. DNA testing is allowing thousands of us to make scientific contributions – a side benefit to having our DNA tested for family history purposes.
Researchers at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.
The work is part of a multi-year collaboration between the two companies begun in early 2015 aimed at identifying new therapeutic targets for Parkinson’s.